Physician profile
Ryan C Goldsmith
NPI 1295050003
$707.32
in general payments reported to CMS, 2019-2025
7 companies · $33.98 in 2025
The $33.98 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $378 · 2020: $41.81 · 2021: $37.13 · 2023: $142 · 2024: $74.49 · 2025: $33.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $230 · Education: $19.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $230.29 |
| Education | $19.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $275.80 | 2019-2024 | Bridion |
| Edwards Lifesciences Corporation | $174.16 | 2019-2024 | Hemosphere |
| Heron Therapeutics, INC. | $121.82 | 2023 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $66.82 | 2020-2021 | |
| Ucb, INC. | $33.98 | 2025 | Bimzelx |
| Medtronic, INC. | $22.62 | 2024 | Bis |
| Depuy Synthes Sales INC. | $12.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Goldsmith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.